Page last updated: 2024-11-05

trihexyphenidyl and Acquired Facial Neuropathy

trihexyphenidyl has been researched along with Acquired Facial Neuropathy in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"Clonic torticollis were less frequently associated to pain."1.28[Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients]. ( Astarloa, R; de Yébenes, JG; Morales, B; Peñafiel, N; Rábano, J, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Astarloa, R1
Morales, B1
Peñafiel, N1
Rábano, J1
de Yébenes, JG1

Other Studies

1 other study available for trihexyphenidyl and Acquired Facial Neuropathy

ArticleYear
[Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients].
    Revista clinica espanola, 1991, Volume: 189, Issue:7

    Topics: Adolescent; Adult; Aged; Blepharospasm; Clonazepam; Facial Nerve Diseases; Female; Humans; Male; Mid

1991